Alterations in ATC/DDD
Overview of ATC/DDD alterations decided at the two previous meetings of the WHO International Working Group for Drug Statistics Methodology. Comments or objections to the ATC/DDD alterations from the latest meeting (temporary codes) should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology within the deadline. If no objections are received, the alterations will be considered final and included in the ATC/DDD Index. The year of implementation in the ATC/DDD Index is given in the list.
Please note that all ATC and DDD alterations are valid and implemented annually.
Change in ATC codes
| INN/generic name | Previous ATC code | New ATC code | Deadline for objection to temporary alterations 1) | Implementation in ATC/DDD index |
|---|---|---|---|---|
| fibrinogen, human | B02BC10 | B02BC30 3) | Final | 2014 |
| ferric oxide polymaltose complexes | B03AC01 | B03AC 2) | Final | 2014 |
| saccharated iron oxide | B03AC02 | B03AC 2) | Final | 2014 |
| iron-sorbitol-citric acid complex | B03AC03 | B03AC 2) | Final | 2014 |
| ferric sorbitol gluconic acid complex | B03AC05 | B03AC 2) | Final | 2014 |
| ferric oxide dextran complexes | B03AC06 | B03AC 2) | Final | 2014 |
| ferric sodium gluconate complex | B03AC07 | B03AC 2) | Final | 2014 |
| bromelains | B06AA11 | D03BA03 | 01.09.2013 | 2014 |
Change of ATC level name
| Previous name | New ATC level name | ATC code | Deadline for objection to temporary alterations | Implementation in ATC/DDD index |
|---|---|---|---|---|
| Adrenergics and other drugs for obstructive airway diseases | Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics | R03AK | Final | 2014 |
| Antiprogestogens | Progesterone receptor modulators | G03XB | 01.09.2013 | 2014 |
| Insulins and analogues for injection, intermediate-acting combined with fast-acting | Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting | A10AD | 01.09.2013 | 2014 |
| Iron trivalent, parenteral preparations | Iron, parenteral preparations | B03AC | Final | 2014 |
| nabiximols | cannabinoids | N02BG10 | 01.09.2013 | 2014 |
| Other oxytocics | Other uterotonics | G02AX | 01.09.2013 | 2014 |
| Oxytocics | Uterotonics | G02A | 01.09.2013 | 2014 |
| reproterol and other drugs for obstructive airway diseases | reproterol and sodium cromoglicate | R03AK05 | Final | 2014 |
| salmeterol and other drugs for obstructive airway diseases | salmeterol and fluticasone | R03AK06 | Final | 2014 |
| thyrotropin | thyrotropin alfa | H01AB01 | Final | 2014 |
Change of ATC code and/or ATC level name
| Previous ATC code and level name | New ATC code and/or level name | ||
| R03AK03 | fenoterol and other drugs for obstructive airway diseases | R03AL01 | fenoterol and ipatroprium bromide |
| R03AK043) | salbutamol and other drugs for obstructive airway diseases | R03AK04 | salbutamol and sodium cromoglicate |
| R03AL02 | salbutamol and ipatroprium bromide | ||
| R03AK073) | formoterol and other drugs for obstructive airway diseases | R03AK07 R03AK08 |
formoterol and budesonide |
| R03AK09 |
formoterol and mometasone |
||
Change of DDDs
| ATC code | Level name | Previous DDD | New DDD | Deadline for objection to temporary alterations | Implementation in ATC/DDD index |
|---|---|---|---|---|---|
| No changes. |
1) Final: indicates that the date for objection has expired
2) Combinations previously classified in B02BC10 should be altered to B02BC30 combinations (existing code)
3) Separate ATC 5th levels for the various combinations (split of code). New ATC 4th level (R03AL) for combinations with anticholinergics
4) Separate ATC 5th levels for the various combinations (split of code). New ATC 4th level (R03AL) for combinations with anticholinergics
2) Combinations previously classified in B02BC10 should be altered to B02BC30 combinations (existing code)
3) Separate ATC 5th levels for the various combinations (split of code). New ATC 4th level (R03AL) for combinations with anticholinergics
4) Separate ATC 5th levels for the various combinations (split of code). New ATC 4th level (R03AL) for combinations with anticholinergics
Last updated: 2013-05-15